Literature DB >> 23022461

Systematic review on factors associated with medication non-adherence in Parkinson's disease.

David James Daley1, Phyo Kyaw Myint, Richard John Gray, Katherine Helen O'Leary Deane.   

Abstract

BACKGROUND: Medication non-adherence is prevalent in Parkinson's disease (PD) and results in substantial motor dysfunction. Although various approaches have been suggested to address non-adherence in PD, good quality evidence of associated factors is limited.
OBJECTIVE: To systematically review the literature on clinical and demographic factors associated with medication non-adherence in PD.
METHODS: We searched five online databases in April 2011 (updated in January 2012): MEDLINE, EMBASE, AMED, PsycINFO and CINAHL for studies reporting data on factors associated with medication non-adherence in people with idiopathic PD. Bibliographies were hand searched to acquire records not identified electronically. Two reviewers independently assessed identified articles for potential inclusion. Data extraction was undertaken using a standardised data extraction form. Methodological quality was assessed against a specially designed quality indicator tool emphasising the detection of threats to internal validity.
RESULTS: We identified 1880 records of which six met inclusion criteria. A total of 772 PD patients were included (mean age 62 years, males 61%). We identified eleven factors (six clinical and five demographic) associated with non-adherence. We ranked each factor in order by weight of overall evidence: mood disorders, cognition, poor symptom control/QoL, younger age/longer disease duration, regimen complexity/polypharmacy, risk taking behaviours, poor knowledge of PD/education, lack of spouse/partner, low income, maintaining employment and gender.
CONCLUSION: Clinicians should be aware of factors associated with medication non-adherence in PD. Targeted interventions should be developed and investigated to establish if addressing factors associated with non-adherence in PD leads to greater medication adherence.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23022461     DOI: 10.1016/j.parkreldis.2012.09.004

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  41 in total

1.  Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities.

Authors:  Daniella Balduino Victorino; Mariana Nejm; Marcia Guimarães-Marques; Fulvio Alexandre Scorza; Carla Alessandra Scorza
Journal:  Pharmaceut Med       Date:  2021-01-07

2.  Predicting adherence of patients with HF through machine learning techniques.

Authors:  Georgia Spiridon Karanasiou; Evanthia Eleftherios Tripoliti; Theofilos Grigorios Papadopoulos; Fanis Georgios Kalatzis; Yorgos Goletsis; Katerina Kyriakos Naka; Aris Bechlioulis; Abdelhamid Errachid; Dimitrios Ioannis Fotiadis
Journal:  Healthc Technol Lett       Date:  2016-09-27

3.  New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.

Authors:  Michael A Kelberman; Elena M Vazey
Journal:  Curr Pharmacol Rep       Date:  2016-09-28

Review 4.  Medication adherence in patients with Parkinson's disease.

Authors:  Naveed Malek; Donald G Grosset
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

5.  Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).

Authors:  Jori E Fleisher; Nabila A Dahodwala; Sharon X Xie; Mark Mayo; Daniel Weintraub; Joshua Chodosh; Judy A Shea
Journal:  J Parkinsons Dis       Date:  2016-04-02       Impact factor: 5.568

6.  Physician trust and depression influence adherence to factor replacement: a single-centre cross-sectional study.

Authors:  D Q Tran; V Barry; A Antun; M Ribeiro; S Stein; C L Kempton
Journal:  Haemophilia       Date:  2016-09-30       Impact factor: 4.287

7.  REM Sleep Behavior Disorder in Parkinson's Disease: Effects on Cognitive, Psychiatric, and Functional outcomes.

Authors:  Zanjbeel Mahmood; Ryan Van Patten; Marina Z Nakhla; Elizabeth W Twamley; J Vincent Filoteo; Dawn M Schiehser
Journal:  J Int Neuropsychol Soc       Date:  2020-05-07       Impact factor: 2.892

8.  No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's Disease.

Authors:  Lisette Bazán-Rodríguez; Amin Cervantes-Arriaga; Rodrigo Llorens-Arenas; Humberto Calderón-Fajardo; Mayela Rodríguez-Violante
Journal:  Mov Disord Clin Pract       Date:  2015-10-28

Review 9.  Is there a Neurobiological Rationale for the Utility of the Iowa Gambling Task in Parkinson's Disease?

Authors:  Michael F Salvatore; Isabel Soto; Helene Alphonso; Rebecca Cunningham; Rachael James; Vicki A Nejtek
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

10.  Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study.

Authors:  Gabriele Helga Franke; Julia Nentzl; Melanie Jagla-Franke; Tino Prell
Journal:  Patient Prefer Adherence       Date:  2021-06-28       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.